Artificial Intelligence

Seegene Debuts World’s First Fully Unattended PCR Automation at ADLM 2025

Breakthrough system set to revolutionize molecular diagnostics by enabling 24/7 sample-to-result PCR testing with no human intervention....

Scopio Labs Launches World’s First Fully Automated AI Blood Morphology System

Breakthrough technology aims to transform hematology diagnostics by combining full-field imaging and AI-driven analysis for faster, more accurate results....

Hyperfine Showcases Swoop® AI-Powered Portable MRI in Dementia Care Studies

Clinical research highlights the potential of Hyperfine’s portable brain imaging system to improve early diagnosis and expand access to neuroimaging in underserved dementia populations....

Philips Secures FDA Clearance for Image-Guided Navigation Technology in Prostate Cancer Care

Breakthrough Minimally Invasive Solution Enhances Precision in Targeted Therapy Procedures, Supporting Improved Outcomes in Prostate Cancer Treatment...

Natus Integrates Moberg CNS Monitor with NeuroWorks for Advanced EEG Capabilities

The integration enhances multimodal brain monitoring by streamlining EEG data access, visualization, and clinical decision-making in critical care environments....

The FDA Is Phasing Out Animal Testing

As regulatory shifts accelerate, next-generation non-animal models must rapidly evolve to ensure safety, efficacy, and innovation in human drug development....

Rebuilding the Drug Repurposing Pipeline with Better Data

How high-quality, integrated datasets are transforming drug repurposing from opportunistic discovery to systematic innovation in therapeutic development. ...

Johnson & Johnson Unveils Global Insights on the Future of Surgical Software

New global report explores the transformative role of digital platforms, AI, and connectivity in reshaping surgical precision, training, and patient outcomes across healthcare systems....

ZEISS CLARUS 700 Gains Regulatory Nod in China, Expanding Ophthalmic Portfolio

The NMPA approval of the ZEISS CLARUS 700 represents a major leap forward in ultra-widefield retinal imaging, offering high-resolution, true color visualization to support early detection and management of complex eye diseases across China....

Oncomine Dx Express Test Gains FDA Approval, Expanding Thermo Fisher’s Precision Oncology Portfolio

The FDA approval of Thermo Fisher’s Oncomine Dx Express Test marks a key advancement in precision oncology, enabling fast, accurate detection of EGFR exon 20 insertion mutations and guiding NSCLC patients to targeted treatments like ZEGFROVY....